Prelude Capital Management’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-72,426
Closed -$4.31M 2424
2019
Q3
$4.31M Buy
+72,426
New +$3.88M 0.19% 64
2017
Q2
Sell
-523
Closed -$29K 1985
2017
Q1
$29K Buy
+523
New +$27.9K ﹤0.01% 1212
2016
Q4
Sell
-3,147
Closed -$140K 1906
2016
Q3
$140K Buy
3,147
+2,628
+506% +$128K 0.01% 698
2016
Q2
$27K Buy
+519
New +$24.8K ﹤0.01% 1196
2015
Q4
Sell
-3,073
Closed -$122K 1797
2015
Q3
$122K Buy
3,073
+2,573
+515% +$120K 0.02% 777
2015
Q2
$22K Sell
500
-1,662
-77% -$68.8K ﹤0.01% 1341
2015
Q1
$86K Buy
2,162
+562
+35% +$16.6K 0.01% 1076
2014
Q4
$35K Sell
1,600
-5,600
-78% -$119K 0.01% 1545
2014
Q3
$134K Buy
+7,200
New +$155K 0.02% 922

Other funds holding CBM

Prelude Capital Management's CBM Position: Q4 2019 in Review

Prelude Capital Management sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 72,426 shares — an estimated $4.31M sold.

Prelude Capital Management first reported a position in CBM in Q3 2014 and held it in 9 quarters. The position peaked at $4.31M in Q3 2019. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

  • Prelude Capital Management reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
  • Prelude Capital Management sold 72,426 Cambrex Corporation shares in Q4 2019, an estimated $4.31M.
  • Prelude Capital Management first reported a position in Cambrex Corporation in Q3 2014 and held it in 9 quarters.
  • Prelude Capital Management's Cambrex Corporation position peaked at $4.31M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.